GARNETH KUIPER: Open Payments
NPI 1174711840 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $184 · 2025 $76
Food & beverage: $76
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
| Corium, LLC | 1 | $11 |
Products named: ARISTADA, INGREZZA, REXULTI, Xelstrym, Azstarys.
Industry payments across SD — which companies pay providers there.
